期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 48, 期 9, 页码 3556-3558出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.48.9.3556-3558.2004
关键词
-
资金
- NIAID NIH HHS [N01-AI25104] Funding Source: Medline
Treatment of Mycobacterium avium disease remains challenging when macrolide resistance develops. We infected C57 beige mice and treated them with mefloquine, SRI-286, and moxifloxacin. SRI-286 (80 mg/kg) was bactericidal in the liver. Mefloquine plus moxifloxacin or mefloquine plus SRI-286 were better than mefloquine alone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据